The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-Invasive Drug Delivery Market Research Report 2025

Global Non-Invasive Drug Delivery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1611371

No of Pages : 99

Ask Your Query

Synopsis

The global Non-Invasive Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery.

Report Scope

The Non-Invasive Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Invasive Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Adherium Limited
  • Capsule Technologies, Inc.
  • Crossject S.A.
  • Diabeloop SA
  • HNS International, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Medtronic Plc.
  • Novartis AG
  • PenJet Corporation
  • PharmaJet
  • Portal Instruments
  • ResMed
  • Sensiron AG
  • Tandem Diabetes Care, Inc.
  • Teva Pharmaceuticals Industries Ltd.

Segment by Type

  • Artificial Pancreas
  • Needle Free Injector
  • Digital Respiratory Devices
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market by Application
1.3.1 Global Non-Invasive Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Drug Delivery Market Perspective (2019-2030)
2.2 Non-Invasive Drug Delivery Growth Trends by Region
2.2.1 Global Non-Invasive Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Invasive Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Non-Invasive Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Non-Invasive Drug Delivery Market Dynamics
2.3.1 Non-Invasive Drug Delivery Industry Trends
2.3.2 Non-Invasive Drug Delivery Market Drivers
2.3.3 Non-Invasive Drug Delivery Market Challenges
2.3.4 Non-Invasive Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Drug Delivery Players by Revenue
3.1.1 Global Top Non-Invasive Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Non-Invasive Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Drug Delivery Revenue
3.4 Global Non-Invasive Drug Delivery Market Concentration Ratio
3.4.1 Global Non-Invasive Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Drug Delivery Revenue in 2023
3.5 Non-Invasive Drug Delivery Key Players Head office and Area Served
3.6 Key Players Non-Invasive Drug Delivery Product Solution and Service
3.7 Date of Enter into Non-Invasive Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Drug Delivery Breakdown Data by Type
4.1 Global Non-Invasive Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Non-Invasive Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Non-Invasive Drug Delivery Breakdown Data by Application
5.1 Global Non-Invasive Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Non-Invasive Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-Invasive Drug Delivery Market Size (2019-2030)
6.2 North America Non-Invasive Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Invasive Drug Delivery Market Size by Country (2019-2024)
6.4 North America Non-Invasive Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Invasive Drug Delivery Market Size (2019-2030)
7.2 Europe Non-Invasive Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Invasive Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Non-Invasive Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Non-Invasive Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Invasive Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-Invasive Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Invasive Drug Delivery Market Size (2019-2030)
9.2 Latin America Non-Invasive Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Invasive Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Non-Invasive Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Non-Invasive Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Invasive Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-Invasive Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adherium Limited
11.1.1 Adherium Limited Company Detail
11.1.2 Adherium Limited Business Overview
11.1.3 Adherium Limited Non-Invasive Drug Delivery Introduction
11.1.4 Adherium Limited Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.1.5 Adherium Limited Recent Development
11.2 Capsule Technologies, Inc.
11.2.1 Capsule Technologies, Inc. Company Detail
11.2.2 Capsule Technologies, Inc. Business Overview
11.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Introduction
11.2.4 Capsule Technologies, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.2.5 Capsule Technologies, Inc. Recent Development
11.3 Crossject S.A.
11.3.1 Crossject S.A. Company Detail
11.3.2 Crossject S.A. Business Overview
11.3.3 Crossject S.A. Non-Invasive Drug Delivery Introduction
11.3.4 Crossject S.A. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.3.5 Crossject S.A. Recent Development
11.4 Diabeloop SA
11.4.1 Diabeloop SA Company Detail
11.4.2 Diabeloop SA Business Overview
11.4.3 Diabeloop SA Non-Invasive Drug Delivery Introduction
11.4.4 Diabeloop SA Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.4.5 Diabeloop SA Recent Development
11.5 HNS International, Inc.
11.5.1 HNS International, Inc. Company Detail
11.5.2 HNS International, Inc. Business Overview
11.5.3 HNS International, Inc. Non-Invasive Drug Delivery Introduction
11.5.4 HNS International, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.5.5 HNS International, Inc. Recent Development
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Company Detail
11.6.2 Inovio Pharmaceuticals, Inc. Business Overview
11.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Introduction
11.6.4 Inovio Pharmaceuticals, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.6.5 Inovio Pharmaceuticals, Inc. Recent Development
11.7 Medtronic Plc.
11.7.1 Medtronic Plc. Company Detail
11.7.2 Medtronic Plc. Business Overview
11.7.3 Medtronic Plc. Non-Invasive Drug Delivery Introduction
11.7.4 Medtronic Plc. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.7.5 Medtronic Plc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Non-Invasive Drug Delivery Introduction
11.8.4 Novartis AG Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.8.5 Novartis AG Recent Development
11.9 PenJet Corporation
11.9.1 PenJet Corporation Company Detail
11.9.2 PenJet Corporation Business Overview
11.9.3 PenJet Corporation Non-Invasive Drug Delivery Introduction
11.9.4 PenJet Corporation Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.9.5 PenJet Corporation Recent Development
11.10 PharmaJet
11.10.1 PharmaJet Company Detail
11.10.2 PharmaJet Business Overview
11.10.3 PharmaJet Non-Invasive Drug Delivery Introduction
11.10.4 PharmaJet Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.10.5 PharmaJet Recent Development
11.11 Portal Instruments
11.11.1 Portal Instruments Company Detail
11.11.2 Portal Instruments Business Overview
11.11.3 Portal Instruments Non-Invasive Drug Delivery Introduction
11.11.4 Portal Instruments Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.11.5 Portal Instruments Recent Development
11.12 ResMed
11.12.1 ResMed Company Detail
11.12.2 ResMed Business Overview
11.12.3 ResMed Non-Invasive Drug Delivery Introduction
11.12.4 ResMed Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.12.5 ResMed Recent Development
11.13 Sensiron AG
11.13.1 Sensiron AG Company Detail
11.13.2 Sensiron AG Business Overview
11.13.3 Sensiron AG Non-Invasive Drug Delivery Introduction
11.13.4 Sensiron AG Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.13.5 Sensiron AG Recent Development
11.14 Tandem Diabetes Care, Inc.
11.14.1 Tandem Diabetes Care, Inc. Company Detail
11.14.2 Tandem Diabetes Care, Inc. Business Overview
11.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Introduction
11.14.4 Tandem Diabetes Care, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.14.5 Tandem Diabetes Care, Inc. Recent Development
11.15 Teva Pharmaceuticals Industries Ltd.
11.15.1 Teva Pharmaceuticals Industries Ltd. Company Detail
11.15.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Introduction
11.15.4 Teva Pharmaceuticals Industries Ltd. Revenue in Non-Invasive Drug Delivery Business (2019-2024)
11.15.5 Teva Pharmaceuticals Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Non-Invasive Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Artificial Pancreas
Table 3. Key Players of Needle Free Injector
Table 4. Key Players of Digital Respiratory Devices
Table 5. Key Players of Other
Table 6. Global Non-Invasive Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Non-Invasive Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Non-Invasive Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Non-Invasive Drug Delivery Market Share by Region (2019-2024)
Table 10. Global Non-Invasive Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Non-Invasive Drug Delivery Market Share by Region (2025-2030)
Table 12. Non-Invasive Drug Delivery Market Trends
Table 13. Non-Invasive Drug Delivery Market Drivers
Table 14. Non-Invasive Drug Delivery Market Challenges
Table 15. Non-Invasive Drug Delivery Market Restraints
Table 16. Global Non-Invasive Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Non-Invasive Drug Delivery Market Share by Players (2019-2024)
Table 18. Global Top Non-Invasive Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2023)
Table 19. Ranking of Global Top Non-Invasive Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Non-Invasive Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Invasive Drug Delivery Product Solution and Service
Table 23. Date of Enter into Non-Invasive Drug Delivery Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Invasive Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2019-2024)
Table 27. Global Non-Invasive Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2025-2030)
Table 29. Global Non-Invasive Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2019-2024)
Table 31. Global Non-Invasive Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2025-2030)
Table 33. North America Non-Invasive Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Non-Invasive Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Non-Invasive Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Non-Invasive Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Non-Invasive Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Non-Invasive Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Non-Invasive Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Non-Invasive Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Non-Invasive Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Non-Invasive Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Non-Invasive Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-Invasive Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Non-Invasive Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Non-Invasive Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Non-Invasive Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 48. Adherium Limited Company Detail
Table 49. Adherium Limited Business Overview
Table 50. Adherium Limited Non-Invasive Drug Delivery Product
Table 51. Adherium Limited Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 52. Adherium Limited Recent Development
Table 53. Capsule Technologies, Inc. Company Detail
Table 54. Capsule Technologies, Inc. Business Overview
Table 55. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product
Table 56. Capsule Technologies, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 57. Capsule Technologies, Inc. Recent Development
Table 58. Crossject S.A. Company Detail
Table 59. Crossject S.A. Business Overview
Table 60. Crossject S.A. Non-Invasive Drug Delivery Product
Table 61. Crossject S.A. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 62. Crossject S.A. Recent Development
Table 63. Diabeloop SA Company Detail
Table 64. Diabeloop SA Business Overview
Table 65. Diabeloop SA Non-Invasive Drug Delivery Product
Table 66. Diabeloop SA Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 67. Diabeloop SA Recent Development
Table 68. HNS International, Inc. Company Detail
Table 69. HNS International, Inc. Business Overview
Table 70. HNS International, Inc. Non-Invasive Drug Delivery Product
Table 71. HNS International, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 72. HNS International, Inc. Recent Development
Table 73. Inovio Pharmaceuticals, Inc. Company Detail
Table 74. Inovio Pharmaceuticals, Inc. Business Overview
Table 75. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product
Table 76. Inovio Pharmaceuticals, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 77. Inovio Pharmaceuticals, Inc. Recent Development
Table 78. Medtronic Plc. Company Detail
Table 79. Medtronic Plc. Business Overview
Table 80. Medtronic Plc. Non-Invasive Drug Delivery Product
Table 81. Medtronic Plc. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 82. Medtronic Plc. Recent Development
Table 83. Novartis AG Company Detail
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Non-Invasive Drug Delivery Product
Table 86. Novartis AG Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. PenJet Corporation Company Detail
Table 89. PenJet Corporation Business Overview
Table 90. PenJet Corporation Non-Invasive Drug Delivery Product
Table 91. PenJet Corporation Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 92. PenJet Corporation Recent Development
Table 93. PharmaJet Company Detail
Table 94. PharmaJet Business Overview
Table 95. PharmaJet Non-Invasive Drug Delivery Product
Table 96. PharmaJet Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 97. PharmaJet Recent Development
Table 98. Portal Instruments Company Detail
Table 99. Portal Instruments Business Overview
Table 100. Portal Instruments Non-Invasive Drug Delivery Product
Table 101. Portal Instruments Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 102. Portal Instruments Recent Development
Table 103. ResMed Company Detail
Table 104. ResMed Business Overview
Table 105. ResMed Non-Invasive Drug Delivery Product
Table 106. ResMed Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 107. ResMed Recent Development
Table 108. Sensiron AG Company Detail
Table 109. Sensiron AG Business Overview
Table 110. Sensiron AG Non-Invasive Drug Delivery Product
Table 111. Sensiron AG Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 112. Sensiron AG Recent Development
Table 113. Tandem Diabetes Care, Inc. Company Detail
Table 114. Tandem Diabetes Care, Inc. Business Overview
Table 115. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product
Table 116. Tandem Diabetes Care, Inc. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 117. Tandem Diabetes Care, Inc. Recent Development
Table 118. Teva Pharmaceuticals Industries Ltd. Company Detail
Table 119. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 120. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product
Table 121. Teva Pharmaceuticals Industries Ltd. Revenue in Non-Invasive Drug Delivery Business (2019-2024) & (US$ Million)
Table 122. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Invasive Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-Invasive Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Artificial Pancreas Features
Figure 4. Needle Free Injector Features
Figure 5. Digital Respiratory Devices Features
Figure 6. Other Features
Figure 7. Global Non-Invasive Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Non-Invasive Drug Delivery Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Non-Invasive Drug Delivery Report Years Considered
Figure 13. Global Non-Invasive Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Non-Invasive Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Non-Invasive Drug Delivery Market Share by Region: 2023 VS 2030
Figure 16. Global Non-Invasive Drug Delivery Market Share by Players in 2023
Figure 17. Global Top Non-Invasive Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Non-Invasive Drug Delivery Revenue in 2023
Figure 19. North America Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Non-Invasive Drug Delivery Market Share by Country (2019-2030)
Figure 21. United States Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Non-Invasive Drug Delivery Market Share by Country (2019-2030)
Figure 25. Germany Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Non-Invasive Drug Delivery Market Share by Region (2019-2030)
Figure 33. China Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Non-Invasive Drug Delivery Market Share by Country (2019-2030)
Figure 41. Mexico Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Non-Invasive Drug Delivery Market Share by Country (2019-2030)
Figure 45. Turkey Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Non-Invasive Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Adherium Limited Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 48. Capsule Technologies, Inc. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 49. Crossject S.A. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 50. Diabeloop SA Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 51. HNS International, Inc. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 52. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 53. Medtronic Plc. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 54. Novartis AG Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 55. PenJet Corporation Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 56. PharmaJet Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 57. Portal Instruments Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 58. ResMed Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 59. Sensiron AG Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 60. Tandem Diabetes Care, Inc. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Non-Invasive Drug Delivery Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock